Rosenberg Matthew Hamilton Bria Cell Therapeutics Corp. Transaction History
Rosenberg Matthew Hamilton
- $345 Million
- Q1 2024
A detailed history of Rosenberg Matthew Hamilton transactions in Bria Cell Therapeutics Corp. stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 12 shares of BCTX stock, worth $12. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 12
-0.0%
Holding current value
$12
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BCTX
# of Institutions
2Shares Held
13Call Options Held
0Put Options Held
0About BriaCell Therapeutics Corp.
- Ticker BCTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,518,000
- Market Cap $15.7M
- Description
- BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...